Registered Nurse in Jbsa Ft. Sam Houston, TX Accepting Medicare
1 Registered Nurse nurses found. Showing 1 - 1
 Patricia Reider Garcia, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: Brooke Army Medical Center (mche-zmd-z), 3551 Roger Brooke Drive, Jbsa Ft. Sam Houston, TX 74823 Phone: 210-916-1680 Fax: 210-916-7483 |
News Archive
Cold weather can trigger Raynaud's disease
Cold weather triggers a painful and sometimes debilitating disorder for millions of Americans who suffer from Raynaud's disease (also known as Raynaud's syndrome or phenomenon). Raynaud's is an autoimmune disorder in which spasms in the blood vessels can interrupt blood flow to the fingers, toes, nose and ears. Exposure to cold triggers the spasms, typically causing the affected area to turn white, then blue, then bright red. Emotional stress can also cause an attack.
Protein complex shown to play pivotal role in stem cell development
Scientists at the Stanford University School of Medicine have identified a protein complex important in controlling whether embryonic stem cells retain their ability to become any cell in the body - a quality called pluripotency - or instead embark on a pathway of maturation and specialization.
PAREXEL genotypes over 10,000 potential study participants to identify 400 CYP2D6 poor metabolizers
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced that it has completed a large and complex pharmacogenetics-based early phase study. The study was conducted in a healthy volunteer population of poor metabolizers of Cytochrome P450 2D6 (CYP2D6), an important enzyme involved in the metabolism of drugs. The study monitored the QTc interval following administration of a neurological treatment, which has been shown to have a higher drug exposure in poor metabolizers of CYP2D6.
OraVerse MAA accepted for review in five key European countries
Sanofi-Aventis Deutschland GmbH and Novalar Pharmaceuticals, Inc. today announced that the Marketing Authorization Application (MAA) for OraVerse has been accepted for review by the regulatory agencies of the United Kingdom (UK), Germany, Italy, France and Spain. OraVerse is the first and only local anesthesia reversal agent that accelerates the return of normal sensation and function following routine dental procedures. OraVerse is approved for use in the U.S. by the Food and Drug Administration and sold by Novalar direct to U.S. dentists.
› Verified 5 days ago